Invista unveil latest refurbishment project at Cambridge Science Park


Commercial Property Agents from across Cambridgeshire gathered at Building 220 Cambridge Science Park to see the transformation of the building following complete refurbishment by landlord Invista Real Estate.

Home to Napp Pharmaceuticals prior to their recent expansion into new purpose built premises elsewhere on the Park, Building 220 benefits from an impressive entrance and central atrium with all the modern fixtures and fittings of Grade A quality office space. The property totals 44,859 sq ft over three levels and may be split into office space from 14,286 sq ft. 

 The launch event began with a tour of the building and guided bus tour of the Cambridge Science Park, and concluded with breakfast overlooking one of the many lakeside areas on the Park. Nick Thompson from LSH and Tom France from Carter Jonas were the lucky winners of a new Apple ipad each in the business card draw.

Harvey Bibby, Office Agent at Bidwells said: “Building 220 is an exceptional building.  We were delighted to host this launch event which enabled so many agents to see the high quality space that is currently available at the Cambridge Science Park.”

Rob Sadler of Savills commented: “Building 220 is a striking building which would make an excellent Headquarters office building for a wide range of R&D based companies.”

Building 220

Building 220, Cambridge Science Park

For further information about Building 220 contact Harvey Bibby at Bidwells on 01223 841841 or Rob Sadler at Savills on 01223 347 000.
ENDS

About Cambridge Science Park

Cambridge Science Park was established by Trinity College in 1970 and is the UK’s most prestigious science park. In 2010, the Park’s 40th anniversary year, the 152 acre site is now home to more than 100 well-known local, national and international companies including Cambridge Consultants, NAPP Pharmaceuticals, The Royal Society of Chemistry and Philips Research. The Park continues to attract a wide range of companies from the R&D sector.

Comments are closed.